Research Article
Management of Metabolic Syndrome with Lifestyle Counseling and Supplementation with Flaxseed
Mageshwari JU1, Trueman P1, Krishnan D2 and Viswanathan V1*
1M.V.Hospital for Diabetes and Diabetes Research Centre (WHO Collaborating Centre for Research, Education and Training in
Diabetes)(IDF centre for Excellence in Diabetes care) Royapuram, India
2D V Living Sciences Pvt Ltd, Chennai, India
*Corresponding author: Viswanathan V, M.V. Hospital for Diabetes and Diabetes Research Centre (WHO Collaborating Centre
for Research, Education and Training in Diabetes)(IDF centre for Excellence in Diabetes care) Royapuram, India, Email: drvijay@mvdiabetes.com
Article Information: Submission: 01/05/2021; Accepted: 08/06/2021; Published: 10/06/2021
Copyright: © 2021 Mageshwari JU, et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Abstract
Background and Objectives: Flaxseed is a rich source of soluble dietary fibre, alpha- linolenic acid(ALA), and secoisolaricires inoldiglucoside (SDG)
all of which have been proven to reduce weight and lipid levels. This study was aimed to examine whether a low dose flaxseed suppresses lipid and reduces
weight.
Method: The study was an internal experimental study. Participants visiting M.V. Hospital for Diabetes in Chennai, were screened whose ages were
between 25 to 55 years. About 108 participants were recruited for the study i.e. 56 men and 44 women. All participants were on OHA and had no change in their
medication. They were divided into two groups, control and trial group with 50 and 58 participants respectively. Both groups received intense diet counselling
and asked to maintain their diet with 30mins of brisk walking daily. Trial group was counselled to include two level tablespoons of powdered flaxseed in 100
ml of water. The Study duration was for 3months.
Results: The initial weight of the control and trial group was 77.75±11.99 and 79.44±12.28 respectively. The final weight of the control group was
78.45±12.01, a increase from the initial weight (p=0.005) while in the trial group there was a decrease in weight from 79.44±12.28 to 75.62±11.73. (P<0.001).
There was a significant decrease in HbA1c from 7.75 ± 0.94 to 6.76 ± 0.68. (P<0.001) and Triglycerides, LDL and Cholesterol.
Interpretation and Conclusion: These finding suggests that flaxseed supplementation helps to reduce weight and helps in glycemic control among
subjects with Type 2 Diabetes.